{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T21:00:32Z","timestamp":1774990832061,"version":"3.50.1"},"reference-count":130,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1053\/j.jvca.2021.05.011","type":"journal-article","created":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T01:28:49Z","timestamp":1621128529000},"page":"2177-2195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Analysis of the ESC\/EACTS 2020 Atrial Fibrillation Guidelines With Perioperative Implications"],"prefix":"10.1053","volume":"36","author":[{"given":"James A.","family":"Nelson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying X.","family":"Gue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon M.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harish","family":"Ramakrishna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2021.05.011_bib0001","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 Update: A report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.05.011_bib0002","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2021.05.011_bib0003","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"18","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"10.1053\/j.jvca.2021.05.011_bib0004","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3390\/medicina55080497","article-title":"Subclinical and asymptomatic atrial fibrillation: Current evidence and unsolved questions in clinical practice","volume":"55","author":"Ballatore","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"10.1053\/j.jvca.2021.05.011_bib0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCULATIONAHA.117.030096","article-title":"Treatment of subclinical atrial fibrillation: Does one plus one always equal two?","volume":"137","author":"Gold","year":"2018","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.05.011_bib0006","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","article-title":"Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060","volume":"34","author":"Krijthe","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2021.05.011_bib0007","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: A report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.05.011_bib0008","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jdiacomp.2018.02.004","article-title":"Diabetes mellitus, blood glucose and the risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies","volume":"32","author":"Aune","year":"2018","journal-title":"J Diabetes Complications"},{"key":"10.1053\/j.jvca.2021.05.011_bib0009","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1378\/chest.15-0229","article-title":"Severity of OSA is an independent predictor of incident atrial fibrillation hospitalization in a large sleep-clinic cohort","volume":"148","author":"Cadby","year":"2015","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2021.05.011_bib0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11886-018-1082-8","article-title":"The impact of diet and lifestyle on atrial fibrillation","volume":"20","author":"Nalliah","year":"2018","journal-title":"Curr Cardiol Rep"},{"key":"10.1053\/j.jvca.2021.05.011_bib0011","first-page":"235","volume":"3","author":"Lip","year":"2017","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1053\/j.jvca.2021.05.011_bib0012","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1161\/CIRCULATIONAHA.117.028981","article-title":"Sex differences and similarities in atrial fibrillation epidemiology, risk factors, and mortality in community cohorts: Results from the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe)","volume":"136","author":"Magnussen","year":"2017","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.05.011_bib0013","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0040-1716408","article-title":"The 4S-AF scheme (stroke risk; symptoms; severity of burden; substrate): A novel approach to in-depth characterization (rather than classification) of atrial fibrillation","volume":"121","author":"Potpara","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.jvca.2021.05.011_bib0014","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.hrthm.2006.07.030","article-title":"Comparison of continuous versus intermittent monitoring of atrial arrhythmias","volume":"3","author":"Ziegler","year":"2006","journal-title":"Heart Rhythm"},{"key":"10.1053\/j.jvca.2021.05.011_bib0015","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.hrthm.2017.01.038","article-title":"Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial Fibrillation","volume":"14","author":"Padfield","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1053\/j.jvca.2021.05.011_bib0016","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1378\/chest.11-0340","article-title":"A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: The Belgrade Atrial Fibrillation study","volume":"141","author":"Potpara","year":"2012","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2021.05.011_bib0017","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/europace\/euy222","article-title":"Atrial fibrillation burden, progression, and the risk of death: A case-crossover analysis in patients with cardiac implantable electronic devices","volume":"21","author":"Piccini","year":"2019","journal-title":"Europace"},{"key":"10.1053\/j.jvca.2021.05.011_bib0018","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.hrthm.2016.05.028","article-title":"EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication","volume":"14","author":"Goette","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1053\/j.jvca.2021.05.011_bib0019","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jacc.2017.06.033","article-title":"Atrial cardiomyopathy: A useful notion in cardiac disease management or a passing fad?","volume":"70","author":"Guichard","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2021.05.011_bib0020","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.amjcard.2015.08.049","article-title":"Stroke risk, factors beyond the CHA(2)DS(2)-VASc score: Can we improve our identification of \"high stroke risk\" patients with atrial fibrillation?","volume":"116","author":"Szymanski","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jvca.2021.05.011_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2020.03.019","article-title":"Regular bleeding risk assessment associated with reduction in bleeding outcomes: The mAFA-II randomized trial","volume":"133","author":"Guo","year":"2020","journal-title":"Am J Med"},{"key":"10.1053\/j.jvca.2021.05.011_bib0022","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2021.05.011_bib0023","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1055\/s-0038-1675400","article-title":"Predicting Thromboembolic and bleeding event risk in patients with non-valvular atrial fibrillation: A systematic review","volume":"118","author":"Borre","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.jvca.2021.05.011_bib0024","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2021.05.011_bib0025","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/CIRCOUTCOMES.108.796185","article-title":"Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: A systematic review","volume":"1","author":"Wan","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1053\/j.jvca.2021.05.011_bib0026","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.118.035418","article-title":"Outcomes associated with apixaban use in patients with end-stage kidney disease and atrial fibrillation in the united states","volume":"138","author":"Siontis","year":"2018","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.05.011_bib0027","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: A randomized clinical trial","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2021.05.011_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2021.05.011_bib0029","doi-asserted-by":"crossref","first-page":"760","DOI":"10.7326\/M13-1467","article-title":"Rate- and rhythm-control therapies in patients with atrial fibrillation: A systematic review","volume":"160","author":"Al-Khatib","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.jvca.2021.05.011_bib0030","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/europace\/eul106","article-title":"Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies","volume":"8","author":"Van Gelder","year":"2006","journal-title":"Europace"},{"key":"10.1053\/j.jvca.2021.05.011_bib0031","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/acem.12091","article-title":"Safety and efficiency of calcium channel blockers versus beta-blockers for rate control in patients with atrial fibrillation and no acute underlying medical illness","volume":"20","author":"Scheuermeyer","year":"2013","journal-title":"Acad Emerg Med"},{"key":"10.1053\/j.jvca.2021.05.011_bib0032","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-8703(98)70031-6","article-title":"A randomized, double-blind comparison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery","volume":"135","author":"Tisdale","year":"1998","journal-title":"Am Heart J"},{"key":"10.1053\/j.jvca.2021.05.011_bib0033","first-page":"47","article-title":"The evidence regarding the drugs used for ventricular rate control","volume":"49","author":"Segal","year":"2000","journal-title":"J Fam Practice"},{"key":"10.1053\/j.jvca.2021.05.011_bib0034","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00003246-200106000-00011","article-title":"Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias","volume":"29","author":"Delle Karth","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2021.05.011_bib0035","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/eurjhf\/hfs036","article-title":"Atrioventricular nodal ablation in atrial fibrillation: a meta-analysis of biventricular vs. right ventricular pacing mode","volume":"14","author":"Chatterjee","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1053\/j.jvca.2021.05.011_bib0036","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/CIRCEP.111.967810","article-title":"Atrioventricular nodal ablation in atrial fibrillation: a meta-analysis and systematic review","volume":"5","author":"Chatterjee","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1053\/j.jvca.2021.05.011_bib0037","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1093\/eurheartj\/ehy555","article-title":"A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS","volume":"39","author":"Brignole","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2021.05.011_bib0038","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/europace\/eux217","article-title":"The influence of progression of atrial fibrillation on quality of life: A report from the Euro Heart Survey","volume":"20","author":"Dudink","year":"2018","journal-title":"Europace"},{"key":"10.1053\/j.jvca.2021.05.011_bib0039","first-page":"648","article-title":"Early cardioversion no better than delayed cardioversion for recent-onset symptomatic atrial fibrillation","volume":"100","author":"Shrikant Kulkarni","year":"2019","journal-title":"Am Fam Physician"},{"key":"10.1053\/j.jvca.2021.05.011_bib0040","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/eurheartj\/ehz585","article-title":"Maximum-fixed energy shocks for cardioverting atrial fibrillation","volume":"41","author":"Schmidt","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2021.05.011_bib0041","first-page":"450","article-title":"Impact of electrical cardioversion on quality of life for the treatment of atrial fibrillation","volume":"33","author":"Sandhu","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1053\/j.jvca.2021.05.011_bib0042","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/eurheartj\/ehx739","article-title":"Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial","volume":"39","author":"Rienstra","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2021.05.011_bib0043","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jemermed.2017.11.016","article-title":"Intravenous flecainide for emergency department management of acute atrial fibrillation","volume":"54","author":"Markey","year":"2018","journal-title":"J Emerg Med"},{"key":"10.1053\/j.jvca.2021.05.011_bib0044","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.jacc.2006.08.037","article-title":"A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: The APAF Study","volume":"48","author":"Pappone","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2021.05.011_bib0045","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/CIRCEP.108.824789","article-title":"Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: Two systematic literature reviews and meta-analyses","volume":"2","author":"Calkins","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1053\/j.jvca.2021.05.011_bib0046","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/europace\/eux013","article-title":"Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: A meta-analysis","volume":"20","author":"Njoku","year":"2018","journal-title":"Europace"},{"key":"10.1053\/j.jvca.2021.05.011_bib0047","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.ijcard.2012.05.008","article-title":"Which are the most reliable predictors of recurrence of atrial fibrillation after transcatheter ablation?: A meta-analysis","volume":"167","author":"D'Ascenzo","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.jvca.2021.05.011_bib0048","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.hrthm.2006.12.036","article-title":"Pulmonary vein antrum isolation","volume":"4","author":"Kanj","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1053\/j.jvca.2021.05.011_bib0049","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/europace\/euu331","article-title":"High rate of durable pulmonary vein isolation after second-generation cryoballoon ablation: Analysis of repeat procedures","volume":"17","author":"Bordignon","year":"2015","journal-title":"Europace"},{"key":"10.1053\/j.jvca.2021.05.011_bib0050","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1111\/j.1540-8167.2006.00652.x","article-title":"Stepwise catheter ablation of chronic atrial fibrillation: Importance of discrete anatomic sites for termination","volume":"17","author":"Jais","year":"2006","journal-title":"J Cardiovasc Electr"},{"key":"10.1053\/j.jvca.2021.05.011_bib0051","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/j.1540-8167.2005.00307.x","article-title":"Catheter ablation of long-lasting persistent atrial fibrillation: Critical structures for termination","volume":"16","author":"Haissaguerre","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1053\/j.jvca.2021.05.011_bib0052","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/CIRCEP.111.963819","article-title":"The cox-maze procedure for lone atrial fibrillation: A single-center experience over 2 decades","volume":"5","author":"Weimar","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1053\/j.jvca.2021.05.011_bib0053","first-page":"583","article-title":"A new era in the surgical treatment of atrial fibrillation: The impact of ablation technology and lesion set on procedural efficacy","volume":"244","author":"Melby","year":"2006","journal-title":"Ann Surg"},{"key":"10.1053\/j.jvca.2021.05.011_bib0054","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13019-019-1012-x","article-title":"Comparison of modified MAZE with minimally invasive monopolar ablation and traditional bipolar radiofrequency ablation in the treatment of atrial fibrillation","volume":"14","author":"Si","year":"2019","journal-title":"J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2021.05.011_bib0055","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jtcvs.2005.10.020","article-title":"Surgical ablation as treatment for the elimination of atrial fibrillation: A meta-analysis","volume":"131","author":"Barnett","year":"2006","journal-title":"J Thorac Cardiov Sur"},{"key":"10.1053\/j.jvca.2021.05.011_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2018.07.099","article-title":"Survival after surgical ablation for atrial fibrillation in mitral valve surgery: Analysis from the Polish National Registry of Cardiac Surgery Procedures (KROK)","volume":"157","author":"Suwalski","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2021.05.011_bib0057","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.hrthm.2019.05.001","article-title":"Five-year outcomes in cardiac surgery patients with atrial fibrillation undergoing concomitant surgical ablation versus no ablation. The long-term follow-up of the PRAGUE-12 Study","volume":"16","author":"Osmancik","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1053\/j.jvca.2021.05.011_bib0058","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/europace\/eux336","article-title":"Surgical ablation of atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials","volume":"20","author":"McClure","year":"2018","journal-title":"Europace"},{"key":"10.1053\/j.jvca.2021.05.011_bib0059","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/icvts\/ivs311","article-title":"How effective is bipolar radiofrequency ablation for atrial fibrillation during concomitant cardiac surgery?","volume":"15","author":"Basu","year":"2012","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1053\/j.jvca.2021.05.011_bib0060","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/icvts\/ivw027","article-title":"Epicardial thoracoscopic ablation versus endocardial catheter ablation for management of atrial fibrillation: A systematic review and meta-analysis","volume":"22","author":"Kim","year":"2016","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1053\/j.jvca.2021.05.011_bib0061","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/ejcts\/ezy475","article-title":"Hybrid versus catheter ablation in patients with persistent and longstanding persistent atrial fibrillation: A systematic review and meta-analysis","volume":"56","author":"van der Heijden","year":"2019","journal-title":"Eur J Cardio-Thorac"},{"key":"10.1053\/j.jvca.2021.05.011_bib0062","first-page":"179","article-title":"New-onset atrial fibrillation in critically ill patients","volume":"22","author":"Sibley","year":"2015","journal-title":"Can Respir J"},{"key":"10.1053\/j.jvca.2021.05.011_bib0063","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0140-6736(16)31258-2","article-title":"Rate control in atrial fibrillation","volume":"388","author":"Van Gelder","year":"2016","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2021.05.011_bib0064","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.05.011_bib0065","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2021.05.011_bib0066","article-title":"Catheter Ablation versus medical therapy for atrial fibrillation","volume":"12","author":"Asad","year":"2019","journal-title":"circulation: Arrhythmia and electrophysiology"},{"key":"10.1053\/j.jvca.2021.05.011_bib0067","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2021.05.011_bib0068","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1161\/CIRCULATIONAHA.111.019935","article-title":"Management of atrial fibrillation in patients with structural heart disease","volume":"125","author":"Darby","year":"2012","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.05.011_bib0069","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1136\/bmj.1.5392.1209","article-title":"Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease","volume":"1","author":"Szekely","year":"1964","journal-title":"Br Med J"},{"key":"10.1053\/j.jvca.2021.05.011_bib0070","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2021.05.011_bib0071","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/CIRCULATIONAHA.116.026793","article-title":"Direct Oral anticoagulants in patients with atrial fibrillation and valvular heart disease other than significant mitral stenosis and mechanical valves: A meta-analysis","volume":"135","author":"Siontis","year":"2017","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.05.011_bib0072","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1093\/ndt\/gfs416","article-title":"Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis","volume":"27","author":"Zimmerman","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jvca.2021.05.011_bib0073","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1105594","article-title":"Stroke and bleeding in atrial fibrillation with chronic kidney disease","volume":"367","author":"Olesen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2021.05.011_bib0074","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ahj.2017.12.017","article-title":"Changes in glomerular filtration rate and outcomes in patients with atrial fibrillation","volume":"198","author":"Fauchier","year":"2018","journal-title":"Am Heart J"},{"key":"10.1053\/j.jvca.2021.05.011_bib0075","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7326\/M19-0087","article-title":"Benefits and harms of oral anticoagulant therapy in chronic kidney disease","volume":"171","author":"Ha","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.jvca.2021.05.011_bib0076","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jama.289.7.871","article-title":"Association of serum digoxin concentration and outcomes in patients with heart failure","volume":"289","author":"Rathore","year":"2003","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2021.05.011_bib0077","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1161\/CIRCULATIONAHA.110.946343","article-title":"Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium","volume":"122","author":"Moons","year":"2010","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.05.011_bib0078","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/eurheartj\/ehaa554","article-title":"2020 ESC Guidelines for the management of adult congenital heart disease: The Task Force for the management of adult congenital heart disease of the European Society of Cardiology (ESC)","volume":"42","author":"Baumgartner","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2021.05.011_bib0079","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/heartjnl-2014-305576","article-title":"Anticoagulation in adults with congenital heart disease: The who, the when and the how?","volume":"101","author":"Jensen","year":"2015","journal-title":"Heart"},{"key":"10.1053\/j.jvca.2021.05.011_bib0080","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/CIRCULATIONAHA.116.026681","article-title":"Burden of arrhythmia in pregnancy","volume":"135","author":"Vaidya","year":"2017","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.05.011_bib0081","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","article-title":"2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy: The Task Force for the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)","volume":"39","author":"Regitz-Zagrosek","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2021.05.011_bib0082","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41569-019-0166-5","article-title":"Postoperative atrial fibrillation: Mechanisms, manifestations and management","volume":"16","author":"Dobrev","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1053\/j.jvca.2021.05.011_bib0083","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/STROKEAHA.118.023921","article-title":"Perioperative\/postoperative atrial fibrillation and risk of subsequent stroke and\/or mortality","volume":"50","author":"Lin","year":"2019","journal-title":"Stroke"},{"key":"10.1053\/j.jvca.2021.05.011_bib0084","first-page":"744","article-title":"Postoperative Atrial fibrillation following coronary artery bypass graft surgery predicts long-term atrial fibrillation and stroke","volume":"18","author":"Konstantino","year":"2016","journal-title":"Isr Med Assoc J"},{"key":"10.1053\/j.jvca.2021.05.011_bib0085","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0140-6736(08)60601-7","article-title":"Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): A randomised controlled trial","volume":"371","author":"Group","year":"2008","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2021.05.011_bib0086","article-title":"Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing non-cardiac surgery","volume":"9","author":"Blessberger","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.jvca.2021.05.011_bib0087","first-page":"2189","article-title":"Amiodarone: guidelines for use and monitoring","volume":"68","author":"Siddoway","year":"2003","journal-title":"Am Fam Physician"},{"key":"10.1053\/j.jvca.2021.05.011_bib0088","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1365-2125.2007.02998.x","article-title":"Effect of dronedarone on renal function in healthy subjects","volume":"64","author":"Tschuppert","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1053\/j.jvca.2021.05.011_bib0089","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1161\/01.CIR.94.3.390","article-title":"Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources","volume":"94","author":"Aranki","year":"1996","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.05.011_bib0090","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/jama.1996.03540040044031","article-title":"Atrial fibrillation following coronary artery bypass graft surgery: Predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group","volume":"276","author":"Mathew","year":"1996","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2021.05.011_bib0091","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00000658-199710000-00011","article-title":"Atrial fibrillation after cardiac surgery: A major morbid event?","volume":"226","author":"Almassi","year":"1997","journal-title":"Ann Surg"},{"key":"10.1053\/j.jvca.2021.05.011_bib0092","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/01.CIR.101.12.1403","article-title":"Atrial fibrillation after coronary artery bypass surgery: A model for preoperative risk stratification","volume":"101","author":"Zaman","year":"2000","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.05.011_bib0093","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1007\/s12630-018-1119-x","article-title":"Predictive ability of perioperative atrial fibrillation risk indices in cardiac surgery patients: A retrospective cohort study","volume":"65","author":"Waldron","year":"2018","journal-title":"Can J Anaesth"},{"key":"10.1053\/j.jvca.2021.05.011_bib0094","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jtcvs.2010.03.011","article-title":"The persistent problem of new-onset postoperative atrial fibrillation: A single-institution experience over 2 decades","volume":"141","author":"Shen","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2021.05.011_bib0095","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.athoracsur.2010.03.100","article-title":"Risk factors for atrial fibrillation after lung cancer surgery: Analysis of the Society of Thoracic Surgeons general thoracic surgery database","volume":"90","author":"Onaitis","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2021.05.011_bib0096","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jtcvs.2006.09.022","article-title":"Video-assisted thoracic surgery does not reduce the incidence of postoperative atrial fibrillation after pulmonary lobectomy","volume":"133","author":"Park","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2021.05.011_bib0097","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtcvs.2005.02.010","article-title":"Atrial fibrillation complicating lung cancer resection","volume":"130","author":"Roselli","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2021.05.011_bib0098","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jtcvs.2003.07.011","article-title":"Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: Analysis of 2588 patients","volume":"127","author":"Vaporciyan","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2021.05.011_bib0099","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jacc.2016.11.024","article-title":"2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation: A Report of the American College of Cardiology Clinical Expert Consensus Document Task Force","volume":"69","author":"Doherty","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2021.05.011_bib0100","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1501035","article-title":"Perioperative bridging anticoagulation in patients with atrial fibrillation","volume":"373","author":"Douketis","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2021.05.011_bib0101","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.04.006","article-title":"Perioperative Heparin bridging in atrial fibrillation patients requiring temporary interruption of anticoagulation: Evidence from meta-analysis","volume":"25","author":"Ayoub","year":"2016","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1053\/j.jvca.2021.05.011_bib0102","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.amjcard.2019.08.020","article-title":"Nation-wide use of periprocedural bridging anticoagulation in patients with atrial fibrillation","volume":"124","author":"Barnes","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jvca.2021.05.011_bib0103","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jamainternmed.2019.2431","article-title":"Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant","volume":"179","author":"Douketis","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1053\/j.jvca.2021.05.011_bib0104","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/AAP.0b013e3181c15c70","article-title":"Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition)","volume":"35","author":"Horlocker","year":"2010","journal-title":"Reg Anesth Pain Med"},{"key":"10.1053\/j.jvca.2021.05.011_bib0105","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/jth.12599","article-title":"Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers","volume":"12","author":"Levi","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2021.05.011_bib0106","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/cts.12398","article-title":"Reversibility of Apixaban anticoagulation with a four-factor prothrombin complex concentrate in healthy volunteers","volume":"9","author":"Nagalla","year":"2016","journal-title":"Clin Transl Sci"},{"key":"10.1053\/j.jvca.2021.05.011_bib0107","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/CIRCULATIONAHA.114.013445","article-title":"Edoxaban effects on bleeding following punch biopsy and reversal by a 4-factor prothrombin complex concentrate","volume":"131","author":"Zahir","year":"2015","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.05.011_bib0108","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1213\/ANE.0000000000003865","article-title":"Society of Cardiovascular Anesthesiologists\/European Association of Cardiothoracic Anaesthetists Practice Advisory for the Management of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery","volume":"128","author":"Muehlschlegel","year":"2019","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2021.05.011_bib0109","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/j.jvca.2015.03.024","article-title":"Obstructive sleep apnea is an independent predictor of postoperative atrial fibrillation in cardiac surgery","volume":"29","author":"Wong","year":"2015","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2021.05.011_bib0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2011.10.011","article-title":"Epidemiology and management of atrial fibrillation in medical and noncardiac surgical adult intensive care unit patients","volume":"27","author":"Kanji","year":"2012","journal-title":"J Crit Care"},{"key":"10.1053\/j.jvca.2021.05.011_bib0111","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1053\/j.jvca.2020.06.078","article-title":"Doing simple things well: Practice advisory implementation reduces atrial fibrillation after cardiac surgery","volume":"34","author":"Buerge","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2021.05.011_bib0112","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1056\/NEJMoa1602002","article-title":"Rate control versus rhythm control for atrial fibrillation after cardiac surgery","volume":"374","author":"Gillinov","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2021.05.011_bib0113","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of Catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: The CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2021.05.011_bib0114","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/europace\/euaa255","article-title":"Complications in pulmonary vein isolation in the Netherlands Heart Registration differ with sex and ablation technique","volume":"23","author":"Mol","year":"2021","journal-title":"Europace"},{"key":"10.1053\/j.jvca.2021.05.011_bib0115","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/europace\/eux233","article-title":"Complications of pulmonary vein isolation in atrial fibrillation: Predictors and comparison between 4 different ablation techniques: Results from the MIddelheim PVI-registry","volume":"20","author":"De Greef","year":"2018","journal-title":"Europace"},{"key":"10.1053\/j.jvca.2021.05.011_bib0116","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003724","article-title":"Incidence and predictors of complications during cryoballoon pulmonary vein isolation for atrial fibrillation","volume":"5","author":"Guhl","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1053\/j.jvca.2021.05.011_bib0117","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.hrthm.2017.01.028","article-title":"Gastric hypomotility after second-generation cryoballoon ablation-Unrecognized silent nerve injury after cryoballoon ablation","volume":"14","author":"Miyazaki","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1053\/j.jvca.2021.05.011_bib0118","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1213\/ANE.0000000000003376","article-title":"A survey of current anesthesia trends for electrophysiology procedures","volume":"127","author":"Nelson","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2021.05.011_bib0119","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.jvca.2010.11.006","article-title":"Sedation and analgesia in the cardiac electrophysiology laboratory: A national survey of electrophysiologists investigating the who, how, and why?","volume":"25","author":"Gaitan","year":"2011","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2021.05.011_bib0120","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.hrthm.2010.10.043","article-title":"General anesthesia reduces the prevalence of pulmonary vein reconnection during repeat ablation when compared with conscious sedation: Results from a randomized study","volume":"8","author":"Di Biase","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1053\/j.jvca.2021.05.011_bib0121","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/pace.12961","article-title":"Moderate Sedation reduces lab time compared to general anesthesia during cryoballoon ablation for af without compromising safety or long-term efficacy","volume":"39","author":"Wasserlauf","year":"2016","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1053\/j.jvca.2021.05.011_bib0122","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/pace.12840","article-title":"Pain reactions during pulmonary vein isolation under deep sedation: Cryothermal versus radiofrequency ablation","volume":"39","author":"Attanasio","year":"2016","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1053\/j.jvca.2021.05.011_bib0123","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/jce.14547","article-title":"Patient-reported outcomes after cryoballoon ablation are equivalent between moderate sedation and general anesthesia","volume":"31","author":"Wasserlauf","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1053\/j.jvca.2021.05.011_bib0124","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/CIRCULATIONAHA.110.976449","article-title":"Safety of percutaneous left atrial appendage closure: Results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry","volume":"123","author":"Reddy","year":"2011","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.05.011_bib0125","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1093\/eurheartj\/ehv730","article-title":"Implant success and safety of left atrial appendage closure with the WATCHMAN device: Peri-procedural outcomes from the EWOLUTION registry","volume":"37","author":"Boersma","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2021.05.011_bib0126","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003695","article-title":"Left atrial appendage closure under intracardiac echocardiographic guidance: Feasibility and comparison with transesophageal echocardiography","volume":"5","author":"Matsuo","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1053\/j.jvca.2021.05.011_bib0127","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jcin.2014.04.014","article-title":"Periprocedural intracardiac echocardiography for left atrial appendage closure: A dual-center experience","volume":"7","author":"Berti","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1053\/j.jvca.2021.05.011_bib0128","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.hrthm.2007.01.014","article-title":"Use of intracardiac echocardiography to guide implantation of a left atrial appendage occlusion device (PLAATO)","volume":"4","author":"Ho","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1053\/j.jvca.2021.05.011_bib0129","article-title":"Transcatheter left atrial appendage closure using intracardiac echocardiographic guidance from the left atrium","volume":"31","author":"Masson","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1053\/j.jvca.2021.05.011_bib0130","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.hrthm.2018.12.013","article-title":"Left atrial appendage closure with the Watchman device using intracardiac vs transesophageal echocardiography: Procedural and cost considerations","volume":"16","author":"Hemam","year":"2019","journal-title":"Heart Rhythm"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077021004225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077021004225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T07:59:59Z","timestamp":1760947199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077021004225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":130,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1053077021004225"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2021.05.011","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of the ESC\/EACTS 2020 Atrial Fibrillation Guidelines With Perioperative Implications","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2021.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}